Abstract
Boceprevir dosing for late responders and null responders: The role of bridging data between treatment-naïve and -experienced subjects
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have